Cost-Consequences Of Using Fluciclovine (F 18) For The Diagnosis And Staging Of Recurring Prostate Cancer
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1039
https://www.valueinhealthjournal.com/article/S1098-3015(17)31373-6/fulltext
Section Title :
HEALTH CARE TREATMENT STUDIES
Section Order :
992
First Page :
A582
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31373-6&doi=10.1016/j.jval.2017.08.1039